Talk:Actibind

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Untitled

I've cut and pasted this section from the article on Aspergillus niger. Will integrate into this article when time allows, unless someone beats me to it :-) Adrian J. Hunter 13:58, 16 October 2006 (UTC)[reply]

Other Uses
[edit]
A T2-RNase protein that is produced by A. niger, ACTIBIND, is under investiation and development at Hebrew University of Jerusalem as an anticancer drug. Due to its ability to bind actin and to interfere with cytoskeletal network structure, ACTIBIND inhibits growth of cell extensions and cell migration in cancer and in endothelial cells. In mice, ACTIBIND inhibited HT-29 xenograft tumor development. In rats, it exerted preventive and therapeutic effects on dimethylhydrazine-induced colonic tumors as well as on the degree of tumor vascularization. An article in the journal Cancer, May 15, 2006, suggests that ACTIBIND is an effective anticarcinogenic and antiangiogenic protein.

Wiki Education assignment: Biochemistry I

This article was the subject of a Wiki Education Foundation-supported course assignment, between 24 January 2023 and 11 May 2023. Further details are available on the course page. Student editor(s): Natleroux (article contribs).

— Assignment last updated by Natleroux (talk) 03:04, 18 April 2023 (UTC)[reply]